Hiddo J L Heerspink Selected Research

Peptides (Polypeptides)

1/2021	Endothelin receptor antagonists for the treatment of diabetic and nondiabetic chronic kidney disease.
1/2018	Predicting albuminuria response to spironolactone treatment with urinary proteomics in patients with type 2 diabetes and hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiddo J L Heerspink Research Topics

Disease

187	Type 2 Diabetes Mellitus (MODY) 05/2024 - 01/2016
118	Chronic Renal Insufficiency 05/2024 - 04/2016
91	Albuminuria 04/2024 - 01/2016
57	Heart Failure 05/2024 - 09/2016
52	Renal Insufficiency (Renal Failure) 05/2024 - 01/2018
48	Diabetic Nephropathies (Diabetic Nephropathy) 02/2024 - 01/2016
38	Kidney Diseases (Kidney Disease) 04/2024 - 01/2016
27	Body Weight (Weight, Body) 01/2024 - 01/2017
26	Chronic Kidney Failure (Chronic Renal Failure) 05/2024 - 04/2016
21	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 04/2016
14	Myocardial Infarction 04/2024 - 09/2016
13	Proteinuria 12/2023 - 12/2017
12	Stroke (Strokes) 04/2024 - 09/2016
11	Diabetes Mellitus 04/2024 - 01/2016
9	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2024 - 01/2016
9	Inflammation (Inflammations) 11/2023 - 01/2018
8	Disease Progression 01/2024 - 01/2016
7	Obesity 03/2024 - 10/2016
7	IGA Glomerulonephritis (IGA Nephropathy) 12/2023 - 01/2021
7	Hypertension (High Blood Pressure) 05/2023 - 12/2017
5	Hyperkalemia 12/2023 - 01/2020
5	Neoplasms (Cancer) 01/2023 - 01/2020
5	Infections 05/2022 - 09/2016
5	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 09/2016
4	Overweight 01/2023 - 01/2021
3	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 04/2024 - 01/2022
3	Acute Coronary Syndrome 01/2024 - 11/2018
3	Atrial Fibrillation 11/2023 - 01/2022
3	Weight Gain 08/2023 - 09/2017
3	Anemia 06/2023 - 12/2020
2	Insulin Resistance 11/2023 - 09/2021

Drug/Important Bio-Agent (IBA)

88	CreatinineIBA 02/2024 - 04/2016
78	dapagliflozinIBA 05/2024 - 05/2017
70	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 10/2017
66	AlbuminsIBA 01/2024 - 04/2016
64	SodiumIBA 04/2024 - 09/2016
56	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2024 - 09/2016
51	CanagliflozinIBA 04/2024 - 01/2017
38	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2016
29	SymportersIBA 04/2024 - 10/2017
27	Sodium-Glucose Transport ProteinsIBA 01/2024 - 09/2016
20	AtrasentanIBA 12/2023 - 01/2017
19	empagliflozinIBA 12/2023 - 09/2016
12	Mineralocorticoid Receptor AntagonistsIBA 04/2024 - 01/2018
12	Angiotensin Receptor AntagonistsIBA 04/2024 - 01/2016
12	Hemoglobins (Hemoglobin)IBA 11/2023 - 09/2016
10	Endothelin Receptor AntagonistsIBA 04/2024 - 11/2019
10	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2024 - 01/2019
9	finerenoneIBA 12/2023 - 10/2020
9	DiureticsIBA 10/2022 - 09/2017
8	omega-Chloroacetophenone (Mace)IBA 04/2024 - 01/2018
8	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2019
7	PotassiumIBA 11/2023 - 01/2020
7	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2023 - 01/2018
6	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2024 - 10/2018
6	Irbesartan FDA LinkGeneric 12/2023 - 01/2016
6	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2023 - 04/2016
6	Losartan (Cozaar)FDA LinkGeneric 12/2023 - 01/2016
6	LinagliptinIBA 11/2023 - 01/2017
6	Uric Acid (Urate)IBA 01/2023 - 01/2018
5	Endothelins (Endothelin)IBA 04/2024 - 01/2017
5	sparsentanIBA 04/2024 - 01/2023
5	Insulin (Novolin)FDA Link 12/2023 - 01/2022
5	Exenatide (Byetta)FDA Link 01/2023 - 10/2019
5	Glucagon-Like Peptide-1 ReceptorIBA 11/2022 - 11/2018
4	aliskiren FDA Link 04/2024 - 04/2016
4	pro-brain natriuretic peptide (1-76)IBA 01/2024 - 12/2018
4	Telmisartan (Micardis)FDA Link 11/2023 - 12/2022
4	Spironolactone (Aldactone)FDA LinkGeneric 03/2022 - 01/2018
4	LDL CholesterolIBA 01/2022 - 01/2021
4	HDL CholesterolIBA 01/2022 - 01/2020
4	HDL LipoproteinsIBA 01/2022 - 01/2020
4	CholesterolIBA 01/2020 - 01/2017
3	semaglutideIBA 03/2024 - 01/2023
3	AldosteroneIBA 03/2024 - 12/2017
3	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 03/2024 - 12/2023
3	LipidsIBA 01/2024 - 01/2022
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2023 - 04/2016
3	Endothelin-1 (Endothelin 1)IBA 12/2023 - 01/2021
3	Eplerenone (Inspra)FDA LinkGeneric 11/2023 - 01/2022
3	Endothelin A ReceptorIBA 11/2023 - 01/2018
3	baricitinibIBA 11/2023 - 01/2023
3	Metformin (Glucophage)FDA LinkGeneric 11/2022 - 01/2017
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 01/2021
3	Lipoproteins (Lipoprotein)IBA 01/2022 - 01/2020
3	DiamondIBA 01/2022 - 01/2020
3	Liraglutide FDA Link 01/2022 - 11/2020
3	Serum AlbuminIBA 08/2021 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2024 - 12/2023
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2023 - 11/2017
2	IronIBA 11/2023 - 08/2021
2	saxagliptin FDA Link 11/2023 - 01/2019
2	Ferritins (Ferritin)IBA 11/2023 - 08/2021
2	ZD4054IBA 11/2023 - 08/2023
2	Endothelin A Receptor AntagonistsIBA 11/2023 - 01/2023

Therapy/Procedure

58	Therapeutics 05/2024 - 01/2016
7	Renal Replacement Therapy (Therapies, Renal Replacement) 04/2024 - 01/2018
6	Precision Medicine 05/2022 - 10/2018
5	Kidney Transplantation 02/2024 - 01/2018
5	Transplantation 11/2023 - 01/2019